SUBSCRIBE
SUBSCRIBE

Mural Oncology

NEWS
3D illustration of a T cell killing a cancer cell
Opinion
Ten Years After a Seminal Approval, Immuno-oncology Is Poised for the Next Revolution
While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing newer iterations that will take cancer care to the next level.
November 4, 2024
 · 
4 min read
 · 
Caroline Loew
IN THE PRESS
Genetown
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
June 5, 2024
 · 
2 min read
Genetown
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
June 4, 2024
 · 
2 min read
Genetown
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024
 · 
8 min read
Business
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
 · 
12 min read
Genetown
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
May 3, 2024
 · 
2 min read
Genetown
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
 · 
2 min read
Genetown
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 9, 2024
 · 
6 min read
Genetown
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 04, 2024
April 4, 2024
 · 
2 min read
Business
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
March 26, 2024
 · 
10 min read
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 4, 2024
 · 
2 min read
Load More
JOBS